肝脏超声造影和增强CT检查对早期肝癌患者的诊断价值  

Diagnostic Value of Liver Contrast-Enhanced Ultrasound and enhanced CT examination in Patients with Early Hepatocellular Carcinoma

作　　者：李永荣 杨波 雷劲松[1] 胡小雪 万登敏[1] Li Yongrong;Yang Bo;Lei Jinsong;Hu Xiaoxue;Wan Dengmin(Anshun People's Hospital,Anshun 561000,Guizhou,China)

机构地区：[1]安顺市人民医院,贵州安顺561000

出　　处：《中外医药研究》2023年第21期141-143,共3页JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH

基　　金：贵州省安顺市科技厅社会发展计划项目[编号:安市科社(2020)08号]。

摘　　要：目的:分析肝脏超声造影和增强CT诊断早期肝癌的效果。方法:选取2020年10月—2023年1月贵州神安顺市人民医院诊治的疑似肝癌患者62例作为研究对象,对其进行肝脏超声造影和增强CT诊断,以病理诊断结果为“金标准”,比较两种诊断方式的诊断效能,记录不同性质的肝脏肿瘤超声造影时相变化时间。结果:病理学诊断结果显示,62例疑似患者中,良性病变和恶性病变患者分别为16例和46例;超声造影灵敏度、特异度、准确度高于增强CT,差异有统计学意义(P<0.05);良性患者始增时间短于恶性患者,达峰时间、减退时间长于恶性患者,差异有统计学意义(P<0.05)。结论:临床上对早期肝癌患者实施诊断时,应用肝脏超声造影的诊断效能更高,良性肝脏肿瘤患者超声造影时相变化更显著,为临床治疗提供可靠的指导依据。Objective:to analyze the effect of liver contrast-enhanced ultrasound and contrast-enhanced CT in diagnosing early hepatocellular carcinoma.Methods:62 patients with suspected diagnose of hepatocellular carcinoma who were admitted in Anshun People's Hospital of Guizhou Province from October 2020 to January 2023 were selected as the study subjects,and were diagnosed with liver contrast-enhanced ultrasound and liver enhanced CT.Pathological diagnosis is the so-called"gold standard",and in the end the diagnostic efficacy of the two modalities was compared with their pathological results.The time of perfusion phase of ultrasound in different liver carcinoma was also recorded.Results:The pathological results showed that among 62 suspected patients,16 and 46 patients had benign and malignant lesions respectively;the sensitivity,specificity and accuracy of ultrasonography were higher than that of enhanced CT,and the difference was statistically significant(P<0.05);the contrast arrival time of benign patients was shorter than that of malignant patients,and Time to peak and the time of regression were longer than that of malignant patients,and the difference was statistically significant(P<0.05).Conclusion:The diagnostic efficacy of liver contrast-enhanced ultrasound is higher in the clinical diagnosis of early-stage hepatocellular carcinoma patients,and the time changes of ultrasonography in patients with benign liver tumors are more significant,which provides a reliable basis for the guidance of clinical treatment.

关 键 词：肝脏超声造影 增强CT 早期肝癌 

分 类 号：R73[医药卫生—肿瘤]